ديجيتال فابلت

الوسم: proteins

  • Innovative Approach to Eliminating Alzheimer’s Brain Damage

    Innovative Approach to Eliminating Alzheimer’s Brain Damage

    Researchers have identified a promising new method that could eventually aid in treating Alzheimer’s disease by helping the brain eliminate harmful proteins. The study, conducted by scientists at the USC Stem Cell research center, centers on a natural internal cleaning process within brain cells rather than inhibiting critical brain chemicals. The findings were published in the journal Neuron.

    Alzheimer’s is the leading cause of dementia, impacting millions globally. The disease gradually impairs memory, cognitive functions, and daily activities. While existing medications may temporarily alleviate symptoms for some, they do not halt the disease’s progression.

    A key feature of Alzheimer’s is the buildup of abnormal proteins in the brain, notably tau. Excessive accumulation of damaged tau within nerve cells disrupts their normal operations, ultimately causing cell death and memory degradation. Scientists have also known that another chemical in the brain, glutamate, plays an important role. Glutamate is vital for learning, memory, and communication among brain cells, but excessive activity can induce harmful changes that promote toxic tau buildup.

    Reducing glutamate levels isn’t a viable solution because it’s essential for proper brain function. Lowering it too much could cause serious side effects, including memory issues, movement problems, or even unconsciousness. Instead, researchers sought a safer way to shield brain cells.

    To explore this, scientists studied tiny lab-grown brain organoids derived from human stem cells, created using cells from both healthy individuals and those with tau-related neurodegenerative conditions. They also conducted experiments on mice genetically predisposed to a form of dementia. When exposed to glutamate, these brain models showed a rapid buildup of toxic tau and increased nerve cell death, especially in tissue with disease-related changes. The team then analyzed gene activity during this process, identifying one gene, KCTD20, as playing a significant role.

    By reducing KCTD20 activity, researchers observed promising results: tau buildup decreased sharply, and many nerve cells remained healthy despite glutamate exposure. Further studies revealed that inhibiting this gene activated lysosomes—small cellular structures that serve as waste disposal and recycling centers by breaking down unwanted material. These lysosomes surrounded and eliminated the toxic tau proteins, enhancing the brain’s natural cleanup system. Instead of preventing tau from forming, this approach facilitated the removal of harmful proteins before they could cause further damage.

    Although this research is still in early stages and has not yet been tested in humans, it opens an exciting path for Alzheimer’s treatment development. Future drugs targeting KCTD20 or boosting lysosome activity could slow the disease’s progression without the side effects associated with altering glutamate levels.

    For those interested in Alzheimer’s prevention, evidence suggests that unhealthy lifestyle choices can increase the risk of developing the disease, while strawberries may serve as a protective food. Other recent studies indicate that oral cannabis extracts might help reduce Alzheimer’s symptoms and that Vitamin E could play a role in preventing Parkinson’s disease.

    © 2026 Knowridge Science Report. All rights reserved.

  • Early Detection: Gut Tests Identify Dementia & Parkinson’s Years Ahead

    Early Detection: Gut Tests Identify Dementia & Parkinson’s Years Ahead

    A recent discovery challenges the traditional view of dementia’s origins, suggesting that early warning signs may originate in the gut rather than the brain. Researchers at the University of Aberdeen have found that analyzing routine gut tissue samples could predict the likelihood of developing dementia and other neurological disorders years before symptoms appear. This breakthrough has the potential to transform how clinicians diagnose and intervene in conditions like Alzheimer’s, Parkinson’s, and motor neuron disease.

    These illnesses, classified as neurodegenerative diseases, gradually deteriorate the brain and nervous system, resulting in memory loss, motor difficulties, and loss of independence. Globally, over 57 million people currently live with dementia, and this number is projected to climb substantially in the coming decades. A major challenge in managing these diseases is their late diagnosis, often after irreversible brain damage has occurred.

    In the study published in Gastroenterology, researchers explored whether early indicators could be found outside the brain, focusing on the gut—which is more accessible through standard medical procedures like biopsies. They examined gut tissue samples from 196 individuals over age 60 who experienced digestive issues but had no prior diagnosis of brain disease. These subjects were monitored for up to 15 years to see who would later develop dementia or related neurological conditions.

    The crucial findings involved proteins. Normally, proteins need to fold into specific shapes to function properly. In neurodegenerative diseases, some proteins misfold, damaging cells and contributing to conditions like Alzheimer’s and Parkinson’s. The scientists specifically looked for three proteins associated with these diseases: TDP-43, tau, and alpha-synuclein. Many participants already had misfolded versions of these proteins in their gut tissue, even though they exhibited no brain symptoms at the time.

    Remarkably, around 60% of the participants showed these abnormal protein structures in their gut. Those with such markers were significantly more likely to develop dementia or similar conditions later on. The accuracy of this prediction was impressive, with the test correctly identifying risk in over 80% of cases.

    One of the most striking aspects was timing: these protein abnormalities appeared nearly seven years before any signs of dementia. This suggests a substantial window for early detection, potentially allowing medical intervention before the disease fully develops.

    The findings support a broader hypothesis that neurodegenerative diseases might originate outside the brain, emphasizing the strong connection between the gut and brain often described as the “gut-brain axis.” However, researchers emphasize that current results show a correlation, not causation. It remains unclear whether misfolded proteins in the gut trigger the disease or if they simply reflect ongoing changes elsewhere in the body.

    The study’s strengths include prolonged follow-up and the use of actual patient samples, but its relatively small sample size indicates the need for further research in larger, more diverse groups. Future clinical trials are necessary to determine if early detection via gut biopsies can lead to effective prevention or treatment.

    Nevertheless, these findings are promising. If validated, a simple gut biopsy might one day help identify at-risk individuals years before symptoms emerge, shifting the focus from treatment to early prevention—potentially improving outcomes greatly.

    For those interested in brain health, it’s worth exploring studies linking vitamin B9 deficiency to higher dementia risk, or how cranberries might help enhance memory. Additional recent research highlights the risks associated with heartburn medications and their potential link to dementia, as well as the protective effects of the MIND diet on cognitive function and dementia prevention.

    Source: University of Aberdeen.